Coverage of pregnant women receiving antiretroviral drugs (ARV) for preventing mother-to-child transmission
(MTCT), 2016

Percentage of pregnant women with HIV/AIDS who received antiretroviral (ARV) drugs for preventing mother-to-child transmission (MTCT) of HIV. Coverage may exceed 100%
where the number of mothers receiving ARV (such as a preventative measure) is greater than the number with HIV.